Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)

Abstract Background Efficacy and safety of human monoclonal antibody erenumab used for migraine prophylaxis have been shown in clinical studies. APOLLON is an open-label, multi-center, single arm study, which permits dose adjustments of erenumab and includes an option for a drug holiday. The finding...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Hartmut Göbel, Eugen Schlegel, Kathrin Jaeger, Sonja Ortler, Lea Leist
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	BMC 2024-09-01
श्रृंखला:	The Journal of Headache and Pain
विषय:	Chronic migraine Episodic migraine Monoclonal antibody Erenumab Long-term safety Tolerability
ऑनलाइन पहुंच:	https://doi.org/10.1186/s10194-024-01860-w
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!